Source: Hematology transfusion and cell therapy. Unidade: FM
Subjects: COVID-19, CORONAVIRUS, LINFOMA, LEUCEMIA
ABNT
PERINI, Guilherme Fleury et al. How to manage lymphoid malignancies during novel 2019 coronavirus (CoVid-19) outbreak: a Brazilian task force recommendation. Hematology transfusion and cell therapy, v. 42, n. 2, p. 103-110, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.htct.2020.04.002. Acesso em: 29 set. 2024.APA
Perini, G. F., Fischer, T., Gaiolla, R. D., Rocha, T. B., Bellesso, M., Teixeira, L. L. C., et al. (2020). How to manage lymphoid malignancies during novel 2019 coronavirus (CoVid-19) outbreak: a Brazilian task force recommendation. Hematology transfusion and cell therapy, 42( 2), 103-110. doi:10.1016/j.htct.2020.04.002NLM
Perini GF, Fischer T, Gaiolla RD, Rocha TB, Bellesso M, Teixeira LLC, Delamain MT, Scheliga AA de S, Ribeiro GN, Pereira J. How to manage lymphoid malignancies during novel 2019 coronavirus (CoVid-19) outbreak: a Brazilian task force recommendation [Internet]. Hematology transfusion and cell therapy. 2020 ; 42( 2): 103-110.[citado 2024 set. 29 ] Available from: https://doi.org/10.1016/j.htct.2020.04.002Vancouver
Perini GF, Fischer T, Gaiolla RD, Rocha TB, Bellesso M, Teixeira LLC, Delamain MT, Scheliga AA de S, Ribeiro GN, Pereira J. How to manage lymphoid malignancies during novel 2019 coronavirus (CoVid-19) outbreak: a Brazilian task force recommendation [Internet]. Hematology transfusion and cell therapy. 2020 ; 42( 2): 103-110.[citado 2024 set. 29 ] Available from: https://doi.org/10.1016/j.htct.2020.04.002